These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 19914467)

  • 1. Future advances in melanoma research.
    Hornyak TJ
    Clin Plast Surg; 2010 Jan; 37(1):169-76. PubMed ID: 19914467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent progress in understanding the pathology of malignant melanoma.
    Kuphal S; Bosserhoff A
    J Pathol; 2009 Dec; 219(4):400-9. PubMed ID: 19771562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic alterations and personalized medicine in melanoma: progress and future prospects.
    Griewank KG; Scolyer RA; Thompson JF; Flaherty KT; Schadendorf D; Murali R
    J Natl Cancer Inst; 2014 Feb; 106(2):djt435. PubMed ID: 24511108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathways to melanoma.
    Ko JM; Velez NF; Tsao H
    Semin Cutan Med Surg; 2010 Dec; 29(4):210-7. PubMed ID: 21277534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Marked genetic differences between BRAF and NRAS mutated primary melanomas as revealed by array comparative genomic hybridization.
    Lázár V; Ecsedi S; Vízkeleti L; Rákosy Z; Boross G; Szappanos B; Bégány A; Emri G; Adány R; Balázs M
    Melanoma Res; 2012 Jun; 22(3):202-14. PubMed ID: 22456166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melanoma stem cells.
    Roesch A
    J Dtsch Dermatol Ges; 2015 Feb; 13(2):118-24. PubMed ID: 25631128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Models and mechanisms in malignant melanoma.
    Benjamin CL; Melnikova VO; Ananthaswamy HN
    Mol Carcinog; 2007 Aug; 46(8):671-8. PubMed ID: 17570501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatic alterations in the melanoma genome: a high-resolution array-based comparative genomic hybridization study.
    Gast A; Scherer D; Chen B; Bloethner S; Melchert S; Sucker A; Hemminki K; Schadendorf D; Kumar R
    Genes Chromosomes Cancer; 2010 Aug; 49(8):733-45. PubMed ID: 20544847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The molecular basis of melanomagenesis and the metastatic phenotype.
    Crowson AN; Magro C; Miller A; Mihm MC
    Semin Oncol; 2007 Dec; 34(6):476-90. PubMed ID: 18083371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conservation of genetic alterations in recurrent melanoma supports the melanoma stem cell hypothesis.
    Sabatino M; Zhao Y; Voiculescu S; Monaco A; Robbins P; Karai L; Nickoloff BJ; Maio M; Selleri S; Marincola FM; Wang E
    Cancer Res; 2008 Jan; 68(1):122-31. PubMed ID: 18172304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular markers in melanoma.
    Kashani-Sabet M
    Br J Dermatol; 2014 Jan; 170(1):31-5. PubMed ID: 23815339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A germline oncogenic MITF mutation and tumor susceptibility.
    Paillerets BB; Lesueur F; Bertolotto C
    Eur J Cell Biol; 2014; 93(1-2):71-5. PubMed ID: 24290354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New drug targets in metastatic melanoma.
    Homet B; Ribas A
    J Pathol; 2014 Jan; 232(2):134-41. PubMed ID: 24027077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonal persistence and evolution during a decade of recurrent melanoma.
    Wang E; Voiculescu S; Le Poole IC; El-Gamil M; Li X; Sabatino M; Robbins PF; Nickoloff BJ; Marincola FM
    J Invest Dermatol; 2006 Jun; 126(6):1372-7. PubMed ID: 16470173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative genome hybridization analysis of laser-capture microdissected in situ melanoma.
    Vincek V; Xu S; Fan YS
    J Cutan Pathol; 2010 Jan; 37(1):3-7. PubMed ID: 19522846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Insights into melanoma from a pathologist's perspective].
    Mihic-Probst D; Beer M
    Praxis (Bern 1994); 2013 Feb; 102(4):219-24. PubMed ID: 23399605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple metastases from cutaneous malignant melanoma patients may display heterogeneous genomic and epigenomic patterns.
    Harbst K; Staaf J; Måsbäck A; Olsson H; Ingvar C; Vallon-Christersson J; Ringnér M; Borg A; Jönsson G
    Melanoma Res; 2010 Oct; 20(5):381-91. PubMed ID: 20848731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular pathogenesis of cutaneous melanocytic neoplasms.
    Ibrahim N; Haluska FG
    Annu Rev Pathol; 2009; 4():551-79. PubMed ID: 19400696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The genetics of melanoma: recent advances.
    Hill VK; Gartner JJ; Samuels Y; Goldstein AM
    Annu Rev Genomics Hum Genet; 2013; 14():257-79. PubMed ID: 23875803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of microgenomic technology for analysis of alterations in DNA copy number and gene expression in malignant melanoma.
    Trent JM; Bittner M; Zhang J; Wiltshire R; Ray M; Su Y; Gracia E; Meltzer P; De Risi J; Penland L; Brown P
    Clin Exp Immunol; 1997 Jan; 107 Suppl 1():33-40. PubMed ID: 9020934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.